Ausdal Financial Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $305K | Buy |
569
+63
| +12% | +$33.8K | 0.02% | 543 |
|
|
2025
Q1 | $212K | Sell |
506
-44
| -8% | -$18.5K | 0.02% | 590 |
|
|
2024
Q4 | $227K | Buy |
550
+5
| +0.9% | +$2.07K | 0.02% | 520 |
|
|
2024
Q3 | $275K | Sell |
545
-58
| -10% | -$29.3K | 0.03% | 424 |
|
|
2024
Q2 | $294K | Sell |
603
-76
| -11% | -$37K | 0.03% | 398 |
|
|
2024
Q1 | $367K | Sell |
679
-12
| -2% | -$6.48K | 0.04% | 329 |
|
|
2023
Q4 | $384K | Buy |
691
+4
| +0.6% | +$2.22K | 0.05% | 299 |
|
|
2023
Q3 | $300K | Sell |
687
-9
| -1% | -$3.94K | 0.04% | 337 |
|
|
2023
Q2 | $350K | Sell |
696
-24
| -3% | -$12.1K | 0.05% | 296 |
|
|
2023
Q1 | $360K | Buy |
720
+2
| +0.3% | +$1K | 0.05% | 301 |
|
|
2022
Q4 | $293K | Buy |
718
+50
| +7% | +$20.4K | 0.04% | 344 |
|
|
2022
Q3 | $218K | Buy |
668
+7
| +1% | +$2.28K | 0.03% | 393 |
|
|
2022
Q2 | $232K | Hold |
661
| – | – | 0.04% | 392 |
|
|
2022
Q1 | $362K | Hold |
661
| – | – | 0.05% | 335 |
|
|
2021
Q4 | $435K | Hold |
661
| – | – | 0.06% | 298 |
|
|
2021
Q3 | $411K | Hold |
661
| – | – | 0.06% | 307 |
|
|
2021
Q2 | $417K | Hold |
661
| – | – | 0.06% | 291 |
|
|
2021
Q1 | $323K | Buy |
661
+6
| +0.9% | +$2.93K | 0.05% | 324 |
|
|
2020
Q4 | $327K | Sell |
655
-10
| -2% | -$4.99K | 0.06% | 296 |
|
|
2020
Q3 | $261K | Buy |
+665
| New | +$261K | 0.06% | 284 |
|